NumerixS Investment Technologies’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-2,200
Closed -$375K 1355
2019
Q4
$375K Buy
2,200
+2,000
+1,000% +$371K 0.07% 303
2019
Q3
$36K Sell
200
-4,100
-95% -$886K 0.01% 797
2019
Q2
$1.12M Buy
+4,300
New +$1.14M 0.32% 63
2018
Q4
Sell
-2,600
Closed -$1.15M 1470
2018
Q3
$1.15M Buy
2,600
+1,000
+63% +$394K 0.22% 128
2018
Q2
$662K Buy
+1,600
New +$580K 0.15% 188
2017
Q3
Sell
-2,800
Closed -$401K 1405
2017
Q2
$401K Sell
2,800
-500
-15% -$67.2K 0.06% 406
2017
Q1
$413K Hold
3,300
0.05% 484
2016
Q4
$372K Buy
+3,300
New +$382K 0.05% 479
2016
Q2
Sell
-6,800
Closed -$645K 1272
2016
Q1
$645K Sell
6,800
-400
-6% -$33.8K 0.07% 382
2015
Q4
$650K Buy
+7,200
New +$611K 0.08% 342

Other funds holding ABMD

NumerixS Investment Technologies's ABMD Position: Q1 2020 in Review

NumerixS Investment Technologies sold out of Abiomed Inc (ABMD) in Q1 2020, closing a stake of 2,200 shares — an estimated $375K sold.

NumerixS Investment Technologies first reported a position in ABMD in Q4 2015 and held it in 10 quarters. The position peaked at $1.15M in Q3 2018. 412 funds tracked by Wall St. Rank hold ABMD as of Q1 2020.

  • NumerixS Investment Technologies reported no remaining Abiomed Inc position as of Q1 2020 after selling out during the quarter.
  • NumerixS Investment Technologies sold 2,200 Abiomed Inc shares in Q1 2020, an estimated $375K.
  • NumerixS Investment Technologies first reported a position in Abiomed Inc in Q4 2015 and held it in 10 quarters.
  • NumerixS Investment Technologies's Abiomed Inc position peaked at $1.15M in Q3 2018.
  • 412 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2020.

Based on NumerixS Investment Technologies's 13F filing for Q1 2020, filed 15 May 2020.